Milos Marinkovic

Director, RA CMC Semaglutide at Novo Nordisk

Copenhagen, Capital Region of Denmark, Denmark

About

Well time menaged, organized, task oriented and focus on achiving targeted goals; individual contributor capabel to fit in the team, always strive to excelence

Experience

  • Novo Nordisk (13 yrs 4 mos)
    • Director, RA CMC Semaglutide
      Mar 2026 - Present · 5 mos

      Leading a dedicated regulatory CMC team focused on the lifecycle management of semaglutide. Responsible for navigating complex global requirements, securing post-market approvals, and spearheading development projects that sustain market leadership.

    • Director
      Oct 2025 - Mar 2026 · 6 mos

      Leading department responsible for CMC activities for selected portfolio of antibodies

    • Director
      Jun 2025 - Oct 2025 · 5 mos

      Heading department within Regulatory CMC area, responsible for development and LCM activities of biologics and ATMPs within rare disease areas.

  • Regulatory Affairs & Quality Assistant at Novo Nordisk Pharma d.o.o. Belgrade
    Feb 2011 - Apr 2013 · 2 yrs 3 mos

    New drug applications Renewals Life cycle management Medical Devices Registrations/Renewals Pharmacovigilance of medical products and medical devices Handling of Change Requests Handling of Non Conformities Handling of Document Control Process

  • Assistant at Emergency Center, Clinical Center of Serbia
    2009 - 2011 · 2 yrs